Position in REGN
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$166,573,457
-$9,242,319 QoQ
Shares Held
215,590
-5.4% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Swedbank AB holds $1,230,784,492 across 20 Biotechnology names. REGN ranks #3 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
11,586,693 | $555,813,663 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
992,108 | $187,558,017 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
215,590 | $166,573,457 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
271,553 | $121,259,276 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
792,187 | $44,750,643 | |
| 6 | EXEL |
Exelixis, Inc.
|
841,778 | $36,103,858 | |
| 7 | INCY |
Incyte Corp
|
362,456 | $34,114,358 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
62,215 | $20,585,076 |
All Filings in REGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $166,573,457 | 215,590 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $175,815,776 | 227,779 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $116,597,929 | 207,370 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $119,855,925 | 228,297 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $127,144,494 | 178,491 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $157,016,359 | 149,363 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $142,580,627 | 135,658 | Shares | Defined | 2024-07-11 | |
| 2023-12-31 | $91,292,097 | 103,943 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $38,436,346 | 46,705 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $31,608,574 | 43,990 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $35,137,074 | 42,763 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $29,427,412 | 40,787 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $26,336,877 | 38,232 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $21,416,639 | 36,230 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $24,409,080 | 34,949 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $21,820,279 | 34,552 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $24,559,414 | 40,582 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $22,569,484 | 40,408 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $19,118,641 | 40,408 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||